Edition:
United States

Profile: Dynasil Corporation of America (DYSL.A)

DYSL.A on American Stock Exchange

1.08USD
3 Jul 2019
Change (% chg)

-- (--)
Prev Close
$1.08
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
133
52-wk High
$1.37
52-wk Low
$1.02

Dynasil Corporation of America, incorporated on February 11, 2008, is engaged in the development, marketing and manufacturing of detection, sensing and analysis technology and optical components, as well as contract research. The Company's products and services are used in a range of application markets, including the homeland security, industrial and medical markets sectors. The Company operates through three segments: Contract Research, Optics and Biomedical. The Contract Research segment consists of the Radiation Monitoring Devices, Inc. (RMD) business unit. The Optics segment operates through four business units: Dynasil Fused Silica, Optometrics Corporation (Optometrics), Hilger Crystals, Ltd (Hilger) and Evaporated Metal Films Corporation (EMF), which manufactures commercial products. The Biomedical segment consists of a business unit, Dynasil Biomedical Corporation (Dynasil Biomedical), a medical technology incubator, which owns rights to certain early-stage medical technologies.

Contract Research

The Company's Contract Research segment's business unit, RMD, is engaged in performing research and development activities for government agencies, including Department of Energy, Department of Defense, Department of Homeland Security, Domestic Nuclear Detection Office, National Institutes of Health and National Aeronautics and Space Administration (NASA). RMD develops advanced technology in materials, sensors and prototype instruments that detect or measure radiation, light, magnetism or sound for use in security, medical and industrial applications. RMD has research expertise in material science, radiation detection, digital imaging technology, magnetic imaging, laser optics and photonics. RMD also provides research for non-governmental entities.

Optics

The Company's optics segment is engaged in the production of optical materials, components and coatings for various applications in the medical, industrial, and homeland security/defense sectors. The Company's Optics segment supplies synthetic crystals, optical materials, components, and coatings that are used in devices, such as baggage scanners, medical imaging systems, optical instruments, lasers, analytical instruments, automotive components, semiconductor/electronic devices, spacecraft/aircraft components and advertising displays.

Biomedical

The Company's Biomedical segment is engaged in development of a tissue sealant product through its Xcede Technologies, Inc. (Xcede) joint venture. Xcede's hemostatic patch is used when techniques are inadequate or impractical during general surgery for the kidneys, liver and spleen. The Xcede Patch is intended to be used during surgical procedures to stop bleeding (Hemostasis).

The Company competes with Raytheon.

Company Address

Dynasil Corporation of America

313 Washington St Ste 403
NEWTON   MA   02458-1626
P: +1617.6686855
F: +1617.6686992

Company Web Links